GGrantIndex
Sort

30,917 grants matching tumor microenvironment

TME Administrative Core

$533,743
Paul R Lockman · West Virginia University · P20 · FY2024 · GM

Understanding how T cell intrinsic androgen receptor activity influences cell differentiation and dysfunction

$533,743
Amy E Moran · Oregon Health & Science University · R37 · FY2023 · CA

Reprogramming the tumor microenvironment via self-amplified RNA (SafeR) circuits

$533,720
Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2019 · CA

Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis

$533,688
Stephen Tc Wong · Methodist Hospital Research Institute · U01 · FY2021 · CA

Mechanisms of response and resistance to KRAS inhibition in pancreatic cancer

$533,684
Andrew James Aguirre · Dana-Farber Cancer Inst · R01 · FY2024 · CA

Macrophage phenotype polarization in clinical neoplasia

$533,583
Jan Matt Van De Rijn · Stanford University · R01 · FY2019 · CA

Epidermal growth factor mitigates radiation-induced hematopoietic failure

$533,540
John P Chute · Duke University · U01 · FY2013 · AI

Mechanisms of dual inhibition of TGFbeta/PD-L1 in HNSCC

$533,483
Xiao-Jing Wang · University Of Colorado Denver · R01 · FY2021 · DE

Mechanisms of dual inhibition of TGFbeta/PD-L1 in HNSCC

$533,483
Xiao-Jing Wang · University Of Colorado Denver · R01 · FY2019 · DE

Mechanisms of dual inhibition of TGFbeta/PD-L1 in HNSCC

$533,483
Xiao-Jing Wang · University Of Colorado Denver · R01 · FY2020 · DE

Controllable In Vivo Genome Editing for Immune-Checkpoint Blockade in Solid Tumors

$533,472
Sheng Tong · Rice University · R01 · FY2018 · EB

Optimizing singlet oxygen dosimetry for photodynamic therapy (PDT)

$533,465
Timothy C Zhu · University Of Pennsylvania · R01 · FY2025 · EB

Targeting posttranslational modifications of CD73 in TNBCs

$533,393
Yong Wan · Emory University · R01 · FY2024 · CA

Assessing Metabolically Reprogrammed and Purified CD19-CAR-T in NHL and CLL

$533,348
Brian Hess · Medical University Of South Carolina · R01 · FY2024 · CA

Novel Gene Therapy for Critical Limb Ischemia and Limb Salvage in Vascular Occlusive Disease

$533,251
Omaida C Velazquez · University Of Miami School Of Medicine · R61 · FY2022 · HL

Clinically-Relevant Regulatory Networks in the Lung Tumor Microenvironment

$533,147
Sylvia Katina Plevritis · Stanford University · U01 · FY2014 · CA

Spatially precise radio-chemo-immunotherapy using antibody conjugates

$533,079
Sunil J Advani · University Of California, San Diego · R01 · FY2025 · CA

Spatially precise radio-chemo-immunotherapy using antibody conjugates

$533,079
Sunil J Advani · University Of California, San Diego · R01 · FY2023 · CA

Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes

$533,033
Mark A Atkinson · University Of Florida · R01 · FY2021 · DK

CD4 helper programs that regulate intratumoral immunity

$532,970
Alice Oliffson Kamphorst · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Assessing Metabolically Reprogrammed and Purified CD19-CAR-T in NHL and CLL

$532,785
Brian Hess · Medical University Of South Carolina · R01 · FY2025 · CA

Clinical Trials Program

$532,741
Margaret M Madeleine · Fred Hutchinson Cancer Research Center · U54 · FY2020 · CA

Preclinical Electron Paramagnetic Resonance Tumor Imager

$532,723
Gareth R Eaton · University Of Denver (Colorado Seminary) · R01 · FY2025 · CA

Collagen fibers and fragments regulate pancreatic cancer metabolism and growth

$532,713
Michael Karin · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA

NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention

$532,625
Pepper J Schedin · Oregon Health & Science University · R01 · FY2014 · CA